<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    ObsEva SA

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About ObsEva SA

    Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $96,800,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Ernest Loumaye, MD, PhD
    • FOUNDED
      2012
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Achillion Pharmaceuticals, Inc.

    Achillion Pharmaceuticals, Inc.

    At Achillion, we are driven to transform the lives of patients and families affect...

    At Achillion, we are driven to transform the li...

    Filing Type:    PU
    CTI BioPharma Corp.

    CTI BioPharma Corp.

    CTI BioPharma is a biopharmaceutical company focused on the acquisition, developme...

    CTI BioPharma is a biopharmaceutical company fo...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Blueprint Medicines Corporation

    Blueprint Medicines Corporation

    Blueprint Medicines is a precision therapy company striving to improve human healt...

    Blueprint Medicines is a precision therapy comp...

    Filing Type:    PU
    Magenta Therapeutics, Inc.

    Magenta Therapeutics, Inc.

    Magenta Therapeutics is a clinical-stage biotechnology company developing therapeu...

    Magenta Therapeutics is a clinical-stage biotec...

    Filing Type:    PU
    Maternova, Inc.

    Maternova, Inc.

    Maternova, Inc. is the trusted resource for cutting edge medical innovations in ne...

    Maternova, Inc. is the trusted resource for cut...

    Amount Raised:    $104,976.00
    Fundraising Status:    EC
    Filing Type:    CF
    Hologic, Inc.

    Hologic, Inc.

    As the leader women’s health, we deliver life-changing and life-saving diagnosti...

    As the leader women’s health, we deliver life...

    Filing Type:    PU
    Viveve Medical, Inc.

    Viveve Medical, Inc.

    Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's in...

    Viveve, Inc., the wholly owned subsidiary of Vi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.